Neurogene Inc.

By person

15 insiders · 134 transactions

78.4×

Rachel McMinn holds 78.4 times base salary in stock. $48.58M of shares against $618.80K in salary for 2025.

Salary from the company's own proxy. The shares are what Rachel McMinn last reported holding, valued at $36.13, the price Common Stock was last bought or sold at on the open market here, on 7 Jul 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

BAKER BROS. ADVISORS LP entity

Director

$75.34M (49)

—

+$75.34M

5,162,141

25.80%

$186.53M

−16.9%

DRACHMAN JONATHAN G

President and CEO

$3.19M (9)

—

+$3.19M

2,373,686

11.86%

$85.77M

+1,010%

Redmile Group, LLC entity

10% owner

$2.01M (9)

$220.15K (4)

+$1.79M

4,041,211

20.19%

$146.03M

+4.5%

Samsara BioCapital GP, LLC entity

10% owner

$1.26M (4)

—

+$1.26M

1,717,127

8.58%

$62.05M

+2.9%

McMinn Rachel

Chief Executive Officer

$969.00K (1)

$74.00K (1) scheduled

+$895.00K

1,344,307

6.72%

$48.58M

+7.5%

Cvijic Christine Mikail

President and CFO

$491.40K (1)

$976.27K (13) scheduled

−$484.87K

84,040

0.4200%

$3.04M

+301.3%

Walkey Carl

Senior Vice President

—

$425.64K (26)

−$425.64K

1,352,489

6.76%

$48.87M

−2.5%

Cobb Stuart

Chief Scientific Officer

—

$244.45K (4) scheduled

−$244.45K

30,497

0.1524%

$1.10M

—

Main David

President and CEO

—

$207.24K (3) scheduled

−$207.24K

71,530

0.3574%

$2.58M

0.0%

Ho Robert

Chief Financial Officer

—

$71.56K (1)

−$71.56K

21,503

0.1075%

$776.99K

+616.8%

LEVITT DANIEL J

Director

—

$49.49K (1) scheduled

−$49.49K

0.0000%

$0.00

—

MacKenzie Lloyd

Chief Operating Officer

—

$19.05K (1) scheduled

−$19.05K

0.0000%

$0.00

—

Jordan Julie

Chief Medical Officer

—

$18.13K (1) scheduled

−$18.13K

12,472

0.0623%

$450.66K

—

Patel Priti

Former Chief Medical Officer

—

$17.94K (3)

−$17.94K

37,313

0.1865%

$1.35M

+521.9%

Smith Sean Michael

Interim CFO, Prin Acct Off

—

$4.44K (3)

−$4.44K

21,637

0.1081%

$781.83K

+298.4%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Smith Sean Michael

10 Aug 2022

Principal Accounting Officer

Sold after exercise

1,655

$0.99

$1.64K

LEVITT DANIEL J

14 May 2018

Director

Sold after exercise

3,906

$12.67

$49.49K

MacKenzie Lloyd

15 Mar 2018

Chief Operating Officer

Sold after exercise

1,302

$14.63

$19.05K

Main David

5 Jun 2017

President and CEO

Sold after exercise

3,625

$13.16

$47.70K

Main David

2 Jun 2017

President and CEO

Sold after exercise

6,000

$13.59

$81.56K

Main David

1 Jun 2017

President and CEO

Sold after exercise

6,000

$13.00

$77.99K

Show all 134 transactions →

By person

Individual transactions

What was left out